Naproxen 500 Mg
Naproxen 500 Mg is a pharmaceutical drug with 9 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
3
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure
Pain Control After Lumbar Spine Fusion
Optimal Treatment of Acute Skeletal Muscle Injury
Clinical Trials (9)
Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure
Pain Control After Lumbar Spine Fusion
Optimal Treatment of Acute Skeletal Muscle Injury
NSAIDs in Sciatica NSAIDS IN SCIATICA
Post Operative Pain Management Through Adductor Canal Block With Bupivacaine for ACL Reconstruction
Pain Management After Surgery
Treatment of Early Phase Achilles Tendinopathy - the Effect of NSAIDs
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9